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FIELD et al. (1970, 1973) and Pritchard
et al. (1972, 1973) reported that the
lymphocytes from patients with malignant
tumours were sensitized to the basic pro-
teins MBP and CaBP (isolated from
human brain and malignant tumours
respectively), thus producing a marked
slowing in the MEM test. They also
pointed out that CaBP was a common
antigen for all cancer, and that CaBP and
MBP shared an antigenic determinant.
Later, Goldstone et al. (1973), Preece et al.
(1974), Lewkonia et al. (1974), Shaw et al.
(1976) and Rawlins et al. (1976) made
similar reports on the MEM test. In addi-
tion, similar results were obtained by
Shelton et al. (1975), Light et al. (1975) and
Flavell et al. (1978) using the macrophage
migration inhibition (MMI) test, and by
Cercek et al. (1977) and Hashimoto (1979)
using the structuredness ofthe cytoplasmic
matrix (SCM) test. However, Forrester et
al. (1977) and Arvilommi et al. (1977)
failed to repeat the above results with
MEM. So it still remains a problem to be
studied further. Moreover, whether the
basic proteins from cerebral malignant
glioma have the same antigenic reactivity
as ordinary MBP and CaBP is anotlher
interesting question. In this report, the
reactivity of lymphocytes from patients
with brain tumours, with other malig,nant
tumours and non-malignant diseases, as
well as normal persons, to GBP and SBP,
isolated from the human cerebral malicg-
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nant glioma and stomach cancer re-
spectively, was measured in the MEM
test.
GBP and SBP were prepared chiefly by
Dickinson's method (Dickinson & Caspary,
1973). Their yields are shown in Table I.
TABLE I. The yield ofgliomna basic protein
(GBP) and basic protein from cancer of
the stomach (SBP) from dried powder
after tissue homogenization
Drie(d
Basic powder'
proteini (g)
GBP 0-4
GBP 1.0
GBP 0(2
GBP 0.2
GBP) 10
GBP 20 5
SBP 1-0
SBP 35-0
SBP 60 0
Aci(d-
extractionIs
I
1
2
Yiel(d
(Ing/g dlrie(I
powrder)
2-74
10-72
17
3.:3
169
18
9
1(0
36
The yield of GBP ranged from 2-74 to
18*0 mg/g dried powder, and of SBP, 9 to
36 mg/g; when the dried powder source
was less than 1 g, the yield fell to 2-17
mg'/g. The yield of two acid extractions
was higher than that of single acid ex-
traction. Basic proteins from the second
extraction evidently had the same antigen
reactivity as from the first extraction.
The yield of SBP were higher than that of
GBP under the same conditions. The poly-
acrylamide electrophoretic pattern showed
that both GBP and SBP were multi-
fractioned preparations of proteins.
Correspondence to I)r Y. D. Slit, De)partme:nt of Biophysics, FIacultv of Basic AMedical Sciences, Shanglhai
First, Medical College, Slhanghai, China.MEM TEST WITH GLIOMA AND STOMACH CANCER EXTRACTS
In incubation, we used two methods:
(1) The single-step method. In each test
tube were placed Medium 199 (pH 7-2),
30 ,ug ofantigen, 7 x 106 guinea-pig macro-
phages and over 0*5 x 106 human lympho-
cytes, the total volume being 1-6 ml.
Another tube with the same inclusions
except antigen was used as a control. Both
tubes were incubated at 23°C for 2 h
before measuring macrophage electro-
phoretic mobility in a "double-blind"
method.
(2) The double-step method. Incubation
was in 2 stages. First, lymphocytes were
incubated with antigen for 2 h at 23°C.
Second, lymphocytes were removed by
centrifugation and 7 x 106 macrophages
were added to the supernatant and incu-
bated for another 2 h at 37°C, and then the
macrophage electrophoretic measurements
were taken as above. For the control
samples all procedures and amounts of
materials were as stated above, but with-
out antigen. A lab.-made cytopherometer
(Lian et al., 1979) and a special electronic
timer (Lian et al., 1980) were used for
MEM (at 250 + 0.30C). In each sample, the
time for 10 macrophages to cover 33 ,um
round trip was recorded. The slowing per-
centage was (t2-t1)/t1 100, with tl=the
travelling time of control tube and t2=
the corresponding time ofthe test sample.
The measurements were made "double
blind".
To obtain reliable results in the MEM
test, the variation in macrophage electro-
phoretic mobility without antigein and
lymphocytes were first analysed (Table II).
TABLE II.-Analysis of variation in MEM
AMean
(/im/sec/
Anialysis V/cm)
Between 289 replications 1013
Between 49 guinea-pigs 1 013
Between gra(lient
potentials (4, 5 anll1
6 V/cm) 1 024
Over time (12 months) 1 013
S.d.
(gm/sec/
V/cm)
0-029
(0098
ARD
Ol/
2-84
9 67
0-0266 2-60
0 047 4-63
ARD) =average relative deviation =s.c./mean.
Twenty-five cases, including 8 ofnormal
persons, 4 of malignant body tumours and
13 of brain tumours, were observed with
single-step and double-step incubation.
The results are shown in Table III.
In order to test whether antigen had
a direct reaction on macrophages, 11
samples of macrophages from 11 guinea-
pigs were prepared and incubated only
with GBP in absence of lymphocytes.
Their average slowing percentage was
0 63 + 2.8, and all samples showednegative
results (Fig. 1(1)).
The MEM results of 388 tests with GBP
as antigen are shown in Table IV and
Fig. 1. The macrophage-slowing percent-
age for 76 normal persons was 0-6+227
(s.d.). The mean plus or minus twice the
standard deviation was taken from the
normal range (i.e. -5 to + 6), a value > 6
being considered positive. Among the 76
normal cases only one woman over 70 was
TABLE Ill.-Comparison between the results (in % slowing) ofsingle-step and double-step
incubation
Case No.
Meani
1 2 3 4 5 6 7 8 9 10 I l 12 13 +s.d.
0-4 2-4 -6-0 1-2 3-9 -1*6 -1-2 -4 0 -0-6 + 3
1.0 3-6 -4 0 0 4 -1*6 5-2 6-4 0.1 0 5 + 2
90 30 7 12-2 19-0 17 7+
14-6 27-0 15-3 22-4 1 99 +5.
;-3
'8
*-8
O
9-0 25-0 17-9 8-3 14-0 27-0 13-2 21-4 23-4 12-5 22-8 13-0 1-0 15-8+6-6
39-1 21-1 14-0 25-5 23-0 35-5 18-9 19-0 11-8 17-0 14-4 10-0 8-0 19-3 + 8-9
Grouips
Normals
Single
Double
Malignant
body tumours
Single
Double
Brain tumours
Single
Double
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TABLE IV. The results of MEM with
GBPfor 388 cases
(C)
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FIG. 1.- Histogram of AIEM tests with
GBP for 388 cases. (1) Only macrophages +
antigen, (2) Normal, (3) Brain tumours
(black= benign, white =malignant), (4)
Malignant body tumours, (5) Benign body
tumours, (6) CNS diseases, (7) Non-tumour
and non-CN8 (liseases.
Group
Normal
Brain tumours
Other malignant
tumours
Other benign tumours
CNS diseases
Non-CNS and non-
tumour diseases
Total
Slowing %
(mean
NO. +s.d.) No.+ve (%)
76 0-6+2-7 1 (1-3)
126 16-2+70 116(92 1)
82
22
25
15-6 + 8-5
3-7+5-1
4-3+7-0
74 (90 2)
7 (31-8)
5 (20)
57 1-0 + 3-9 3 (5*3)
.388
non-tumour and non-CNS, only 3 (5-3%0)
showed positive results, the average slow-
ing being 100+ 3.970o.
The MEM results of 149 cases with
SBP as antigen are shown in Table V and
Fig. 2. None of 10 normal persons showed
positive result. Their slowing was 1-5 +
1-4%0. Among 9 cases of brain tumours, 8
(89%) showed positive, and the average
slowing was 14-5 + 6.9%0 Arnong 38 cases
of stomach cancers, 36 were positive
(94.70%) and the average slowing was
13.6+470o. Among 60 cases of other
malignant tumours, 56 were positive
(93.300) and their average slowing ranged
from 10.8% to 14-6%. Among 32 cases of
non-tumour and non-CNS, 2 were positive
positive. Among 126 cases of brain
tumours (70 malignant and 56 benign),
116 showed positive results (92.1%) with
the average slowing 16-2+7-0%. Among
the 70 malignant cases, 69 showed positive
with average slowing 17-6 + 8 6%. Among
the 56 benign cases, 47 showed positive,
with average slowing 14.6 + 7.00o. Both
had marked slowing action, but the former
had fewer negative than the latter. Among
82 cases of other malignant tumours, 74
(90.2%) were positive and the average
slowing was 15a6 + 8a50% Among 22 cases
of benign body tumours, 7 (31.8%)
showed positive results and the average
slowing was 3 68 + 5.10%. Among 25 cases
of central nervous system (CNS) diseases,
5 (20%) showed positive, with average
slowing 4.3 + 7.0%. Among 57 ca,ses of
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FIG. 2. Histogram of MEAM tests witlh
SBP for 149 cases. (1) Normal, (2) Stomach
cancers, (3) Brain tumours, (4) Otlher malig-
nant body tumours, (5) Non-tumour and
non-CNS diseases.
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TABLE V.-The results of MEM with SBPfor 149 cases
Group
Normal
Brain tumours
Stomachi canicers
Livrer cancers
Colon cancers
Breast cancers
Oesophageal carcinoma
Melanoma
Miscellaneous cancers
Non-tumour an(d non-CNS dliseases
Total
No.
10
9
:18
12'
22
9 60
4
5
32
149
(6 3 0) and the average slowing was
3d1 + 5.300.
This MEM variation (Table II) shows
that average relative deviation (ARD) due
to differences between individual ani-
mals is the highest (9*67%), with
monthly variations next (4-63%) and
operational error or potential gradients
the lowest (284%, 2-60%). It must be
emphasized that measurement of MEM of
the control and test samples should be
carried out in identical conditions (such as
macrophages from the same animal and
the same potential gradient) in order to
minimize the deviation due to operation
error above. Ifmacrophages from different
animals are mixed for use in the MEM
test, the deviation between results would
be greater and might affect the accuracy
ofthe test.
By analysing the results of 25 cases with
both incubation methods (Table III), the
slowing percentage of 8 normal persons in
the MEM test was near zero, but that of 4
cases of malignant body tumour and 13
cases of brain tumour was higher with the
double step than with the single step.
Among 25 cases, 24 had coincident results
and the other (a brain tumour) gave
different results, double-step being posi-
tive, single-step negative. From the data
it appears that the double-step method
may be more useful for detecting malig-
nant and brain tumours. In this assay, the
other 512 cases were investigated by the
double-step method.
There appeared to be no reduction in
MEM when macrophage samples from 11
Slowing %
(mean + s.d.)
1-5+ 1-4
14-5+6-9
13-6+4-5
12-8+ 10-8
12-3+4-3
10-8+5-1
14-6+ 3-6
14-5+ 2-4
120+3-5
3-1+ 5-3
No. +ve (%O)
0 (0)
8 (890)
36 (94 7)
10 (83 3)
20 (91-0) -
9 (100))
8 (100) 56 (93-30o) 4 (100)
5 (100)
2 (6.3)
guinea pigs were incubated with GBP in
the absence of human lymphocytes. This
suggests that the reduced MEM is induced
by the action of lymphocytes in patients
with brain or malignant tumours by
stimulation of GBP, but not due to the
direct action ofGBP on macrophages. The
"double-blind" method for electrophoretic
measurement was used so that our results
could be more objective.
Using our GBP as an antigen, the inci-
dence of positive MEM tests was only
1.3% in normal persons, and 53%0 in non-
tumour and non-CNS diseases, while over
90o% in brain tumours (both malignant
and benign) and other malignant tumours,
but 31o8% in benign body tumours and
20% in CNS disease. The results coincide
with those of our preliminary report (Shi
et at., 1979). When using our SBP as an
antigen, th6 positive incidence was 0% in
normal persons and 6-3% in non-tumour
and non-CNS diseases, while over 89% in
brain tumours, stomach cancer and other
malignant body tumours. Though GBP
and SBP could produce some positive
tests in benign body tumours and CNS
diseases, they had a high positive inci-
dence in brain tumours (benign or malig-
nant) and other malignant body tumours.
Moreover, they also gave an extremely
high negative incidence in normal and
non-tumour and non-CNS diseases. Thus
our results showed that our GBP was
probably similar to our SBP, as well as to
theCaBPofField etal. (1973) thatourGBP
and SBP had common antigen reactivity,
and that our results were similar to Field's
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and others, but different from Forrester's
and Arvelommi's. It is believed that the
MEM test is not only a valuable tool for
diagnosing cancers, but also a good tool for
studying the cellular immunological state
of cells and detecting antigen.
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